These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

442 related items for PubMed ID: 24492421

  • 1. Cardiovascular death in kidney recipients treated with renin-angiotensin system blockers.
    Opelz G, Döhler B.
    Transplantation; 2014 Feb 15; 97(3):310-5. PubMed ID: 24492421
    [Abstract] [Full Text] [Related]

  • 2. Angiotensin-converting enzyme inhibitor or angiotensin II type 1 receptor antagonist therapy is associated with prolonged patient and graft survival after renal transplantation.
    Heinze G, Mitterbauer C, Regele H, Kramar R, Winkelmayer WC, Curhan GC, Oberbauer R.
    J Am Soc Nephrol; 2006 Mar 15; 17(3):889-99. PubMed ID: 16481415
    [Abstract] [Full Text] [Related]

  • 3. Renin-angiotensin system blockade and kidney transplantation: a longitudinal cohort study.
    Hernández D, Muriel A, Abraira V, Pérez G, Porrini E, Marrero D, Zamora J, González-Posada JM, Delgado P, Rufino M, Torres A.
    Nephrol Dial Transplant; 2012 Jan 15; 27(1):417-22. PubMed ID: 21622985
    [Abstract] [Full Text] [Related]

  • 4. No impact of hyperkalaemia with renin-angiotensin system blockades in maintenance haemodialysis patients.
    Han SW, Won YW, Yi JH, Kim HJ.
    Nephrol Dial Transplant; 2007 Apr 15; 22(4):1150-5. PubMed ID: 17255126
    [Abstract] [Full Text] [Related]

  • 5. Comparative effectiveness of angiotensin receptor blockers vs. angiotensin-converting enzyme inhibitors on cardiovascular outcomes in patients initiating peritoneal dialysis.
    Shen JI, Saxena AB, Montez-Rath ME, Leng L, Chang TI, Winkelmayer WC.
    J Nephrol; 2017 Apr 15; 30(2):281-288. PubMed ID: 27485007
    [Abstract] [Full Text] [Related]

  • 6. Comparative risk for angioedema associated with the use of drugs that target the renin-angiotensin-aldosterone system.
    Toh S, Reichman ME, Houstoun M, Ross Southworth M, Ding X, Hernandez AF, Levenson M, Li L, McCloskey C, Shoaibi A, Wu E, Zornberg G, Hennessy S.
    Arch Intern Med; 2012 Nov 12; 172(20):1582-9. PubMed ID: 23147456
    [Abstract] [Full Text] [Related]

  • 7. Blood pressure, antihypertensive treatment, and graft survival in kidney transplant patients.
    Hillebrand U, Suwelack BM, Loley K, Lang D, Reuter S, Amler S, Pavenstädt H, Hausberg M, Büssemaker E.
    Transpl Int; 2009 Nov 12; 22(11):1073-80. PubMed ID: 19624495
    [Abstract] [Full Text] [Related]

  • 8. Effect of renin-angiotensin system inhibitors on long-term survival in patients treated with beta blockers and antiplatelet agents after acute myocardial infarction (from the MONICA/KORA Myocardial Infarction Registry).
    Amann U, Kirchberger I, Heier M, Zirngibl A, von Scheidt W, Kuch B, Peters A, Meisinger C.
    Am J Cardiol; 2014 Aug 01; 114(3):329-35. PubMed ID: 24927969
    [Abstract] [Full Text] [Related]

  • 9. Determinants and patterns of renin-angiotensin system inhibitors' prescription in the first year following kidney transplantation.
    Thilly N, Bayat S, Alla F, Kessler M, Briançon S, Frimat L.
    Clin Transplant; 2008 Aug 01; 22(4):439-46. PubMed ID: 18318741
    [Abstract] [Full Text] [Related]

  • 10. Renoprotective effect of renin-angiotensin-aldosterone system blockade in patients with predialysis advanced chronic kidney disease, hypertension, and anemia.
    Hsu TW, Liu JS, Hung SC, Kuo KL, Chang YK, Chen YC, Hsu CC, Tarng DC.
    JAMA Intern Med; 2014 Mar 01; 174(3):347-54. PubMed ID: 24343093
    [Abstract] [Full Text] [Related]

  • 11. Is Chronic Kidney Disease Progression Influenced by the Type of Renin-Angiotensin-System Blocker Used?
    Silvariño R, Rios P, Baldovinos G, Chichet MA, Perg N, Sola L, Saona G, De Souza N, Lamadrid V, Gadola L.
    Nephron; 2019 Mar 01; 143(2):100-107. PubMed ID: 31203280
    [Abstract] [Full Text] [Related]

  • 12. Therapeutic approaches in lowering albuminuria: travels along the renin-angiotensin-aldosterone-system pathway.
    Heerspink HJ.
    Adv Chronic Kidney Dis; 2011 Jul 01; 18(4):290-9. PubMed ID: 21782135
    [Abstract] [Full Text] [Related]

  • 13. Effect of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers on all-cause mortality, cardiovascular deaths, and cardiovascular events in patients with diabetes mellitus: a meta-analysis.
    Cheng J, Zhang W, Zhang X, Han F, Li X, He X, Li Q, Chen J.
    JAMA Intern Med; 2014 May 01; 174(5):773-85. PubMed ID: 24687000
    [Abstract] [Full Text] [Related]

  • 14. Effects of withdrawing vs continuing renin-angiotensin blockers on incidence of acute kidney injury in patients with renal insufficiency undergoing cardiac catheterization: Results from the Angiotensin Converting Enzyme Inhibitor/Angiotensin Receptor Blocker and Contrast Induced Nephropathy in Patients Receiving Cardiac Catheterization (CAPTAIN) trial.
    Bainey KR, Rahim S, Etherington K, Rokoss ML, Natarajan MK, Velianou JL, Brons S, Mehta SR, CAPTAIN Investigators.
    Am Heart J; 2015 Jul 01; 170(1):110-6. PubMed ID: 26093871
    [Abstract] [Full Text] [Related]

  • 15. To RAS or not to RAS? The evidence for and cautions with renin-angiotensin system inhibition in patients with diabetic kidney disease.
    St Peter WL, Odum LE, Whaley-Connell AT.
    Pharmacotherapy; 2013 May 01; 33(5):496-514. PubMed ID: 23576066
    [Abstract] [Full Text] [Related]

  • 16. Comparative Effectiveness of Combination Therapy with Statins and Angiotensin-Converting Enzyme Inhibitors versus Angiotensin II Receptor Blockers in Patients with Coronary Heart Disease: A Nationwide Population-Based Cohort Study in Korea.
    Lee J, Lee S.
    Pharmacotherapy; 2018 Nov 01; 38(11):1095-1105. PubMed ID: 30225928
    [Abstract] [Full Text] [Related]

  • 17. [Effect of early postoperative use of ACEI/ARB or diuretics on the incidence of acute kidney injury after cardiac surgery in elderly patients].
    Hu PH, Chen YH, Liang XL, Li RZ, Li ZL, Jiang F, Shi W.
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2013 Jul 01; 25(7):394-8. PubMed ID: 23834935
    [Abstract] [Full Text] [Related]

  • 18. ACE Inhibitor Benefit to Kidney and Cardiovascular Outcomes for Patients with Non-Dialysis Chronic Kidney Disease Stages 3-5: A Network Meta-Analysis of Randomised Clinical Trials.
    Zhang Y, He D, Zhang W, Xing Y, Guo Y, Wang F, Jia J, Yan T, Liu Y, Lin S.
    Drugs; 2020 Jun 01; 80(8):797-811. PubMed ID: 32333236
    [Abstract] [Full Text] [Related]

  • 19. Angiotensin-converting enzyme inhibitors (ACEIs), not angiotensin receptor blockers (ARBs), are preferred and effective mode of therapy in high cardiovascular risk patients.
    Vijan SG.
    J Indian Med Assoc; 2009 Mar 01; 107(3):178-82. PubMed ID: 19810392
    [Abstract] [Full Text] [Related]

  • 20. Effect of pre-transplantation use of angiotensin-converting enzyme inhibitor or angiotensin receptor blocker in kidney transplant recipients-propensity score-matched analysis.
    Lee J, Jung CY, Kim H, Kim HJ, Ko Y, Kwon H, Shin S, Kim YH, Park SK, Baek CH.
    J Nephrol; 2024 Jul 01; 37(6):1589-1597. PubMed ID: 38684638
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.